Thank you for attending this session. We want to hear your feedback to help us improve future meetings. Please complete this quick survey and let us know your thoughts.
Please rate the following:
1) Scientific delivery
a.Presentation: Pneumococcal disease prevention: Building on the success of vaccines
- Charles Feldman (South Africa)*
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
b.Expert discussion: Current challenges and future directions in pneumococcal vaccination strategies
- Charles Feldman and regional panellists*
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
2) Meeting Organization
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
Strongly agreeAgreeNeutralDisagreeStrongly disagree
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
CompletelyMostlySomewhatNot at all
Completely
Mostly
Somewhat
Not at all

COVID-19, coronavirus disease 2019

Pfizer Pte Ltd
80 Pasir Panjang Road, #16-81/82
Mapletree Business City, Singapore 117372
Tel: +65-6403 8888 Fax: +65-6403 8868 Website: www.pfizer.com.sg
Intended for Healthcare Professionals only

PP-PRV-SGP-0057/16JUNE2022